Spero Therapeutics, Inc. ( SPRO) - Stock Earnings
SPRO Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Aug. 12, 2026, midnight | — / — | — | — / — | — |
SPRO Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | 31.5 million USD | 39.7 million USD |
| 2026Q1 | -7.2 million USD | 258000 USD |
| 2026Q2 | -9.6 million USD | — USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
SPRO Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 22.8 million USD | 103.8 million USD |
| 2024 | -68.6 million USD | 48.0 million USD |
| 2025 | 8.6 million USD | 59.6 million USD |
| 2026 Est. | — | — |
SPRO
Price: $1.20
Earnings Per Share: 0.28 USD
P/E Ratio: 4.43
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 179389
Market Capitalization: 72.2 million